News | Clinical Decision Support | December 06, 2016

NDSC Expands CareSelect to Cover Multiple Service Lines and Care Settings

Expanded clinical guidelines cover procedures, medications and laboratory testing at the point of care

National Decision Support Company, NDSC, CareSelect clinical decision support, expanded service lines, RSNA 2016

December 6, 2016 — National Decision Support Company (NDSC) recently announced expanded CareSelect solutions that cover a wide variety of care settings and healthcare services including the ABIM Foundation's Choosing Wisely Campaign.

NDSC's CareSelect helps to accurately render clinical guidelines for electronic medical record (EMR) delivery, leveraging existing clinical documentation and creating a seamless user experience within the EMR workflow. The expanded solution now includes clinical and business logic covering medication, lab and blood management, as well as a complete set of advisories based on the Choosing Wisely Campaign.

The CareSelect platform exchanges data with the EMR in real time to perform clinical calculations against evidence-based guidelines and pathways. This enables the caregiver to choose alternate tests or clinical pathways based on the guideline. This advanced functionality can be coupled with the CareSelect benchmarking and reporting tools to ensure success.

The CareSelect platform enables the delivery, management and localization of clinical guidelines that range from simple appropriate use criteria to complex level of care admission level logic. The platform simplifies the configuration of the EMR and leverages all available clinical data to ensure that guidelines are accurately delivered.

For more information: www.nationaldecisionsupport.com

Related Content

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019.

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019. Photo by Dave Fornell.

Feature | Artificial Intelligence | February 07, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
News | Remote Viewing Systems | December 27, 2019
December 27, 2019 — The Radiological Society of North America (RSNA) and Carequality have developed the Imaging Data
Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) Protecting Access to Medicare Act (PAMA) will require physicians to consult a CMS-approved clinical decision support mechanism before ordering advanced imaging exams for fee-for-service Medicare patients
News | Clinical Decision Support | December 26, 2019
December 26, 2019 — Effective Jan.
Applying radiology and cardiology PACS ergonomics expertise to help pathologists avoid repetitive stress injuries that can arise from adopting digital pathology
News | PACS Accessories | October 04, 2019
Applying radiology and cardiology PACS ergonomics expertise to help pathologists avoid repetitive stress injuries that...
NetDirector Launches Cloud-based PDF to DICOM Conversion Service
News | PACS | August 08, 2019
NetDirector, a cloud-based data exchange and integration platform, has diversified their radiology automation options...
Videos | Radiology Business | August 02, 2019
Association for Medical Imaging Management (AHRA) President ...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).